Update on classic Kaposi sarcoma therapy: New look at an old disease
- 1 December 2008
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 68 (3) , 242-249
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Classic Kaposi Sarcoma in the United States over the last two decades: A clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi SarcomaLaboratory Investigation, 2008
- Management of AIDS-related Kaposi's sarcomaThe Lancet Oncology, 2007
- Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcomaJournal of the European Academy of Dermatology and Venereology, 2006
- Role of Pegylated Lyposomal Doxorubicin (PLD) in Systemic Kaposi's Sarcoma: A Systematic ReviewInternational Journal of Immunopathology and Pharmacology, 2006
- Risk Factors for Classical Kaposi's SarcomaJNCI: Journal of the National Cancer Institute, 2002
- Classic Kaposi sarcomaCancer, 2000
- Classic Kaposi’s Sarcoma: Low-Dose Interferon Alfa TreatmentDermatology, 1998
- Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2bArchives of Dermatology, 1996
- Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastineCancer, 1994
- Oral Etoposide for Kaposi’s Mediterranean SarcomaDermatology, 1988